Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2017 Nov 14;69(12):1780–1788. doi: 10.1002/acr.23201

Table 1.

Demographics of SLE and ILE cohorts defined by the 1997 ACR SLE classification criteria.

All SLE All ILE P* ILE with major
clinical features+
Other ILE P*
n 3397 440 86 354
Sex
Female, n (%) 3050 (89.8) 386 (87.7) 0.213 72 (83.7) 314 (88.7) 0.280
Age, y
Average (Range) 42.0 (8–82) 46.1 (9–81) <0.001 42.8 (11–72) 47.0 (9–81) 0.010
Race/ethnicity, n
(%)
European 1518 (44.7) 241 (54.8) <0.001 36 (41.9) 205 (57.9) 0.010
American
African American 1093 (32.2) 105 (23.9) <0.001 27 (31.4) 78 (22.0) 0.092
Hispanic 244 (7.2) 21 (4.8) 0.076 6 (7.0) 15 (4.2) 0.269
Asian American 130 (3.8) 18 (4.1) 0.889 6 (7.0) 12 (3.4) 0.136
American Indian 104 (3.1) 12 (2.7) 0.812 2 (2.3) 10 (2.8) 1.0
Pacific Islander 5 (0.1) 1 (0.2) 0.519 0 (0.0) 1 (0.3) 1.0
Mixed 283 (8.3) 40 (9.1) 0.653 8 (9.3) 32 (9.0) 1.0
Unknown 20 (0.6) 2 (0.5) 1.0 1 (1.2) 1 (0.3) 0.353
*

Bold P-values are significant (P<0.05).

+

Pericarditis, renal disease, neurologic disease, hemolytic anemia, or thrombocytopenia.

Comparisons performed by Fisher’s test; all other categorical variables were compared by Chi-square and age by t-test.